Brief: Cue Biopharma To Receive $7.5 Million Preclinical Milestone Payment From Boehringer Ingelheim Collaboration And License Agreement
08/04/2026 13:13
April 8 (Reuters) - Cue Biopharma Inc CUE.O: CUE BIOPHARMA TO RECEIVE $7.5 MILLION PRECLINICAL MILESTONE PAYMENT FROM BOEHRINGER INGELHEIM COLLABORATION AND LICENSE AGREEMENT CUE BIOPHARMA INC - ELIGIBLE FOR UP TO $337.5 MILLION IN ADDITIONAL MILESTONE PAYMENTS AND ROYALTIES CUE BIOPHARMA INC - EXPECTS TO RECEIVE $7.5 MILLION PAYMENT IN MAY 2026 Source text: ID:nGNX3zbfpP Further company coverage: CUE.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cue Biopharma
See all newsU.S. STOCKS ON THE MOVE-Insmed, Marvell, Meta
US STOCKS ON THE MOVE-Meta, Marvell Technology, Insmed
U.S. STOCKS ON THE MOVE-Accenture, Arhaus, Alkermes
Cue Biopharma surges after positive results from mid-stage study for CUE-221
Brief: Cue Biopharma Announces Positive Topline Results From Cue-221 Phase 2 Study In Chronic Spontaneous Urticaria